Tetracycline regulator expression alters the transcriptional program of mammalian cells

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Hackl, Hubert ^a   Rommer, Anna ^b   Konrad, Torsten A ^b   Nassimbeni, Christine ^b   Wieser, Rotraud ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; TETRACYCLINE REGULATORY PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; TETRACYCLINE;

ARTICLE; AUTOREGULATION; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAMMAL CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FOLDING; UPREGULATION; CELL STRAIN U937; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION;

MAMMALIA;

ANTI-BACTERIAL AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; TETRACYCLINE; TRANSCRIPTION, GENETIC; U937 CELLS;

EID: 77958597550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013013     Document Type: Article

References (22)

1. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.
2. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
3. Shockett P, Difilippantonio M, Hellman N, Schatz D (1995) A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A 92: 6522-6526.
4. Vignali D, Carson R, Chang B, Mittler R, Strominger J (1996) The two membrane proximal domains of CD4 interact with the T cell receptor. J Exp Med 183: 2097-2107.
5. Boer J, Bonten-Surtel J, Grosveld G (1998) Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 18: 1236-1247.
6. Bromleigh V, Freedman L (2000) p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells. Genes Dev 14: 2581-2586.
7. Caslini C, Shilatifard A, Yang L, Hess J (2000) The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation. Proc Natl Acad Sci U S A 97: 2797-2802.
8. McConnell M, Chevallier N, Berkofsky-Fessler W, Giltnane J, Malani R, et al. (2003) Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression. Mol Cell Biol 23: 9375-9388.
9. Caslini C, Serna A, Rossi V, Introna M, Biondi A (2004) Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. Leukemia 18: 1064-1071.
10. Hakansson P, Lassen C, Olofsson T, Baldetorp B, Karlsson A, et al. (2004) Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Leukemia 18: 538-547.
11. Hakansson P, Segal D, Lassen C, Gullberg U, Morse H, 3rd, et al. (2004) Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays. Exp Hematol 32: 476-482.
12. Hultquist A, Cetinkaya C, Wu S, Castell A, Erlandsson A, et al. (2004) Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts. Mol Cancer Res 2: 464-476.
13. Liang H, Samanta S, Nagarajan L (2005) SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells. Oncogene 24: 2625-2634.
14. Meester-Smoor M, Janssen M, Grosveld G, de Klein A, van IW, et al. (2008) MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression. Carcinogenesis 29: 2025-2034.
15. Konrad T, Karger A, Hackl H, Schwarzinger I, Herbacek I, et al. (2009) Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol 86: 813-822.
16. Rice K, Hormaeche I, Doulatov S, Flatow J, Grimwade D, et al. (2009) Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood 114: 5499-5511.
17. Morimoto M, Kopan R (2009) rtTA toxicity limits the usefulness of the SP-CrtTA transgenic mouse. Dev Biol 325: 171-178.
18. Fornerod M, Boer J, van Baal S, Jaegle M, von Lindern M, et al. (1995) Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10: 1739-1748.
19. Livak K, Schmittgen T (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
21. Huang da W, Sherman B, Lempicki R (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
22. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, et al. (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25: 1091-1093.